BANGLADESH, DRUGS
To meet its objective of health for all by AD 2000, Bangladesh has decided to open its doors for importing pharmaceutical ingredients, packaging products and finished drugs. Medicines inadequately produced in the country can now be imported without any restrictions. However, curbs will remain on drugs manufactured on a large scale in the country.
The decision announced in mid-November reverses an import ban imposed in 1982 during President Ershad's regime. The aim of the ordinance was to help the domestic drugs industry flourish by keeping out competition.
Related Content
- Predicting and designing therapeutics against the Nipah virus
- Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster-randomized trial
- Biomarkers of environmental enteropathy are positively associated with immune responses to an oral cholera vaccine in Bangladeshi children
- Efficacy of a Russian-backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double-blind, placebo-controlled trial
- Addressing cryptosporidium infection among young children in low-income settings: The crucial role of new and existing drugs for reducing morbidity and mortality
- Environmental enteropathy, oral vaccine failure and growth faltering in Infants in Bangladesh